Elevated plasma levels of lipoprotein (a) (Lp (a)) are associated with increased cardiovascular risk in several clinical studies. However, there is a lack of data supporting a positive association …

Nov 29, 2018 · Introduction: Despite convincing evidence toward causal role of Lipoprotein (a) in occlusive arterial disease, the data is conflicting when it comes to venous thromboembolism …

Herein, we present a review of existing literature relating to periproce-dural management of antithrombotics in patients undergoing LP and draw recommendations from these for use in …

This paper summarises the existing literature on the topic and offers recommendations to guide periprocedural antithrombotic management for LP, based on the consolidation of the best …

Aug 17, 1999 · We investigated the little-characterized role of Lp (a) as a risk factor for venous thromboembolic diseases, alone and in conjunction with established thrombophilic risk factors …

Materials and methods: We investigated Lp (a) in 128 patients with spontaneous symptomatic deep vein thrombosis (DVT, group 1), 105 with spontaneous symptomatic pulmonary …

We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase …

The results of the study by Nowak-Goottl et al. showed higher levels of Lp (a) lipoprotein in the serum of patients with DVT. The significance of elevated serum Lp (a) lipoprotein was also …

Jul 4, 2022 · Traditionally, lumbar puncture (LP) has been used to evaluate for SAH in patients with negative noncontrast head CT scan who have high suspicion for SAH (primarily if the CT …

Jan 6, 2016 · Lipoprotein (a) [Lp(a)] plays a crucial role in the pathogenesis of deep vein thrombosis (DVT). The purpose of this study was to investigate whether Lp(a) serum levels at …